FIBCD1 and malignant colon neoplasm: Based on FIBCD1’s ability to dampen inflammatory responses in mucosal tissues, we hypothesized that enhanced FIBCD1 expression would lead to decreased intestinal inflammation and reduce the development of colitis-associated colon cancer.